DRGem

DRGem EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DRGem (263690.KQ) as of Oct 21, 2026 is 9.03 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 10.56 B KRW — a change of -14.52% (lower).

EBITDA

9.03 BKRW

YoY

-14.52%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DRGem is 2025 9.03 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DRGem was 2024 10.56 B KRW. It decreases by -14.52% lower compared to the previous year.

The DRGem EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
4.60 B KRW
Jan 1, 2019
5.11 B KRW
Jan 1, 2020
23.72 B KRW
Jan 1, 2021
15.18 B KRW
Jan 1, 2022
18.00 B KRW
Jan 1, 2023
12.16 B KRW
Jan 1, 2024
10.56 B KRW
Jan 1, 2025
9.03 B KRW
The DRGem EBITDA history
YEAREBITDAYoY
9.03 BKRW-14.52%
10.56 BKRW-13.14%
12.16 BKRW-32.48%
18.00 BKRW+18.62%
15.18 BKRW-36.02%
23.72 BKRW+364.52%
5.11 BKRW+10.99%
4.60 BKRW+1.54%
4.53 BKRW+46.35%
3.10 BKRW+57.63%
1.96 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DRGem Stock analysis

What does DRGem do? DRGEM Corp. generates revenue through the manufacturing and sale of diagnostic X-ray systems, including analog, digital, and retrofit models, as well as high voltage X-ray generators and mobile X-ray systems. The company serves domestic and international markets with its product portfolio, which features veterinary digital radiography systems and digital upgrade systems. Key customers include healthcare facilities requiring medical imaging solutions, while the firm focuses on both established diagnostic equipment and modern digital upgrades for existing systems. The firm's product range spans diagnostic analog X-ray systems, diagnostic digital X-ray systems, and diagnostic retrofit X-ray systems, alongside components like high voltage X-ray generators. These products are distributed domestically and internationally, targeting hospitals, clinics, and veterinary practices seeking advanced imaging technology. DRGEM Corp. emphasizes digital transformation in radiography, offering systems that modernize legacy equipment through retrofit solutions. DRGEM Corp. monetizes its expertise in X-ray technology by providing comprehensive solutions for medical and veterinary sectors. Its diagnostic digital X-ray systems and mobile X-ray systems cater to evolving healthcare demands, while digital upgrade systems enable cost-effective modernization of older equipment. The company's revenue streams are driven by direct sales of these specialized products to healthcare providers and veterinary institutions across multiple regions. DRGem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DRGem stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DRGem is 9.03 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DRGem changed from 10.56 B KRW to 9.03 B KRW, representing a -14.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) DRGem since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s DRGem historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — DRGem

All Key Metrics — DRGem